FN2 Earnings Intelligence
Tenet Healthcare Corporation ratios (quarterly)
Tenet Healthcare Corporation (THC) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $2,999 | $2,625 | $2,975 | $2,967 | $2,170 |
| + Debt | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - |
| Revenue | $5,223 | $5,271 | $5,289 | $5,368 | $5,628 |
| % Growth | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| % Margin | - | - | - | - | - |
| EBITDA | $1,149 | $1,031 | $1,107 | $1,525 | $1,716 |
| % Margin | 22.0% | 19.6% | 20.9% | 28.4% | 30.5% |
| Net Income | $622 | $522 | $579 | $906 | $1,045 |
| % Margin | 11.9% | 9.9% | 10.9% | 16.9% | 18.6% |
| Diluted EPS | $4.27 | $3.14 | $3.86 | $8.01 | $9.84 |
| % Growth | - | - | - | - | - |
| Operating Cash Flow | $815 | - | - | $1,641 | - |
| CapEx | $173 | - | - | $180 | - |
| Free Cash Flow | $642 | - | - | $1,461 | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue | $5,223 | $5,271 | $5,289 | $5,368 | $5,628 |
| Gross Profit | - | - | - | - | - |
| EBITDA | $1,149 | $1,031 | $1,107 | $1,525 | $1,716 |
| Net Income | $622 | $522 | $579 | $906 | $1,045 |
| Diluted EPS | $4.27 | $3.14 | $3.86 | $8.01 | $9.84 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $2,999 | $2,625 | $2,975 | $2,967 | $2,170 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $815 | - | - | $1,641 | - |
| Capital Expenditure | $173 | - | - | $180 | - |
| Free Cash Flow | $642 | - | - | $1,461 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | - | - | - | - | - |
| EBITDA Margin | 22.0% | 19.6% | 20.9% | 28.4% | 30.5% |
| Net Margin | 11.9% | 9.9% | 10.9% | 16.9% | 18.6% |
| FCF Margin | 12.3% | - | - | 27.2% | - |
| Diluted EPS Growth | - | - | - | - | - |
Get the THC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.